Bladder Carcinoma study: Biospecimen Collection vs Device Usage
Official title The Vanguard Study: Testing a New Way to Screen for Cancer
ClinicalTrials.gov ID: NCT06995898
What this study is testing
- What it's testing
- The study wants to see how well a multi‑cancer detection test works and how people react to the results.
- Who it's for
- Adults aged 45 to 75 who do not have cancer.
- What's involved
- Participants will be randomly put into one of two test groups or a control group. Those in the test groups will have a blood test that checks for many cancers. The control group will not get the test. All participants will be followed to see what happens after the test results.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Ages 45-75 years old
- Agree to provide blood samples for possible MCD testing at enrollment and at 1 year following enrollment
- Agree to allow collection of information from their medical records for study-related purposes
- Understand and be able to complete informed consent and participant questionnaires in English, Spanish, or Arabic
- Note: Eligibility for Spanish and Arabic languages are at the Hub's discretion
You likely can't join if
- Solid malignant tumor or blood cancer diagnosis, with or without treatment, within the last 5 years
- Note: Persons with a history of in situ cancers (e.g., ductal carcinoma in situ of the breast, cervical cancer in situ, atypical melanocytic...
- Ongoing cancer diagnostic work-up
- Ongoing participation in another study of an investigational cancer screening test or technology not currently utilized in routine clinical practice
- Currently breastfeeding or pregnant, or planning to become pregnant in the next year
- History of solid organ or hematopoietic transplantation at any time, or blood transfusion within the last 30 days
The study team makes the final eligibility decision.
Where it is enrolling
- Pleasanton, California, United States
- San Diego, California, United States
- Cheyenne Wells, Colorado, United States
- Denver, Colorado, United States
- Fort Collins, Colorado, United States
- Greeley, Colorado, United States
- Lafayette, Colorado, United States
- Lone Tree, Colorado, United States
- Loveland, Colorado, United States
- Honolulu, Hawaii, United States
- Bethesda, Maryland, United States
- Brownstown, Michigan, United States
- Chesterfield, Michigan, United States
- Clinton Township, Michigan, United States
- Dearborn, Michigan, United States
- Detroit, Michigan, United States
- Grosse Pointe Farms, Michigan, United States
- Livonia, Michigan, United States
- Novi, Michigan, United States
- Plymouth, Michigan, United States
+ 21 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Pleasanton, California, United States; San Diego, California, United States; Cheyenne Wells, Colorado, United States; Denver, Colorado, United States; Fort Collins, Colorado, United States; Greeley, Colorado, United States and 35 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.